After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback